PATENT CLAIM ANALYSIS

Application Number: 16000322
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["424", "480000"]

Abstract:
In various embodiments, the present invention is directed to oral pharmaceutical compositions. For example, in some embodiments, the present invention is directed to taste-masked compositions. In some embodiments, the taste masked compositions comprise a highly water soluble drug such as amphetamine, e.g., in the form of a salt such as amphetamine sulfate. In various embodiments, the present invention is directed to taste-masked, orally disintegrating compositions.

Claim (Index 23):
The orally disintegrating pharmaceutical composition of  claim 22 , wherein after administration of a dose equivalent to 30 mg of racemic amphetamine sulfate, the orally disintegrating pharmaceutical composition provides two or more of the following:\n an AUC inf  ranging from about 80% to about 125% of about 400-600 hr*ng/mL; a C max  ranging from about 80% to about 125% of about 25-35 ng/mL; or a T max  ranging from about 80% to about 125% of about 2-4 hrs.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 2.08108
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12772776', '11223819', '12057177', '14661639', '13844537']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8008411801984849
- 35 USC 102 Novelty (BERT): 0.5422898567605028
- Combined Prediction Score: 0.7749860478546867
- Mean Citation Score: 375.237624
- Max Citation Score: 407.90445
- Similarity Product: 268.90051400474306

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test